Pfizer's Dividend Yield Rises to 6.3% Amid Concerns Over Future Prospects
Pfizer's stock has declined 55% from its 2021 high, pushing its dividend yield to 6.3%. The drop is attributed to challenges in its pharmaceutical pipeline, including the abandonment of a GLP-1 weight-loss drug candidate and weaker-than-expected long-term vaccine sales. Investors are questioning the sustainability of the dividend amid these issues.
Tickers: $PFE
Topics: dividend yield GLP-1 drug candidate Pfizer pharmaceutical industry stock price decline